Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

This clinical trial update reports the Phase 3 study of ESK-001 evaluating its efficacy and safety in patients with moderate to severe plaque psoriasis, which h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ESK-001

Snippet

Sponsor: Alumis Inc | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED